Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
University of Southern California · Berlin Institute of Health at Charité - Universitätsmedizin Berlin · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
493
total citations
- FWCI
- 42.33
- Percentile
- 100%
- References
- 168
Citations per year
Authors
7- CFChristian FlugelCorresponding
University of Southern California, Berlin Institute of Health at Charité - Universitätsmedizin Berlin
- RGRobbie G. Majzner
Stanford Medicine, Stanford University
- GKGiedre Krenciute
St. Jude Children's Research Hospital
- GDGianpietro Dotti
University of North Carolina at Chapel Hill
- SRStanley R. Riddell
University of Washington, Fred Hutch Cancer Center
Topics & keywords
Topics
Keywords
- Chimeric antigen receptor
- Medicine
- Antigen
- Cancer research
- CD19
- Toxicity
- Cell
- Immunotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- AFAssisi Foundation of Memphis
- UOUniversity of Southern CaliforniaAward: P30CA014089
- NINational Institutes of HealthAwards: R01NS121249, P30CA014089
- UOUniversity of California, San Francisco
- NCNational Cancer InstituteAwards: R01NS121249, P30CA014089
- NINational Institute of Neurological Disorders and StrokeAward: R01NS121249